RNADD has assembled a best-in-class leadership team to execute the business strategy
A 30 year C-Suite healthcare executive Mr. Oberman has served as CEO of Concordia International Corp., Sagent Pharmaceuticals Inc., Teva Pharmaceuticals Americas, Teva Pharmaceuticals International, and Novopharm Ltd. Mr. Oberman is currently the President & CEO of Apotex Inc. He previously served on the Board of Directors of Dr. Reddy’s Laboratories Ltd.
John Erickson has 30 years of C-Suite and senior executive level leadership experience in life sciences and diagnostics with Johnson & Johnson, Abbott Labs, Bio-Rad Labs, ITC/Nexus Diagnostics and RapidBio systems. Mr. Erickson has been responsible for the development, commercialization, and management of over 36 products with cumulative revenues in excess of $4 billion.
20 years of financial experience as the former CFO of three NASDAQ publicly traded healthcare companies. Mr. Blacher brings deep knowledge in investment banking having worked with Lehman Brothers, Deutsche Bank, and Cowen Inc., as well as experience in IPO's, follow-on offerings, M&A transactions, and public and private financings.
A 30 year C-Suite healthcare executive Mr. Oberman has served as CEO of Concordia International Corp., Sagent Pharmaceuticals Inc., Teva Pharmaceuticals Americas, Teva Pharmaceuticals International, and Novopharm Ltd. Mr. Oberman is currently the President & CEO of Apotex Inc. He previously served on the Board of Directors of Dr. Reddy’s Laboratories Ltd.
John Erickson has 30 years of C-Suite and senior executive level leadership experience in life sciences and diagnostics with Johnson & Johnson, Abbott Labs, Bio-Rad Labs, ITC/Nexus Diagnostics and RapidBio Systems. Mr. Erickson has been responsible for the development, commercialization, and management of over 36 products with cumulative revenues in excess of $4 billion.
Patrice Allibert, a PhD in molecular biology and microbiology has more than 35 years of experience in four major biotechnology companies. He is the Former CEO of GenePOC, a company acquired by Meridian BioSciences. Patrice was Vice President R&D and Strategic Innovation for Molecular Infectious Diseases at Becton Dickinson where he developed and launched multiple diagnostic tests for hospital acquired infections.
Mike C. Kaufmann is a board member of and advisor to both public and private companies, and a former Fortune 15 CEO and CFO. He spent 32 years of his career at Cardinal Health, a global, integrated healthcare solutions company providing vital products, world class services and customized solutions for providers along the continuum of care. He spent the last five years as CEO leading the company to record revenues, driving improvements in its portfolio and cost structure, and managing through the impacts of Covid, particularly those on employees and the supply chain.
Jordan Kupinsky has more than 20 years of experience in merchant banking, investment banking and law. He is currently Managing Partner of Windsor Private Capital and has served on several public and private company boards including Concordia International, Atlas Financial Holdings, Xceed Mortgage Corporation, and Perk Inc.
.jpg)
David Komlos is a CEO, board member, keynote speaker, and early-stage investor. He is Co-author of Cracking Complexity, and works closely with top leaders in healthcare, private equity, entertainment, and large enterprise.
Alec Burger is the Former President and CEO of GE Capital, and Chairman of GE Capital Aviation Services (GECAS). Alec was responsible for financial operations in 34 countries and ~$150B in assets. He has served as Vice Chairman of the Connecticut Chapter of the National Multiple Sclerosis Society and a Board Member of the Stepping Stones Museum for Children in Norwalk, CT.
Charles R. Black is Chairman of Prime Policy Group, and is widely recognized as a leading public affairs professional. Serving as a principal legislative and public affairs advisor to several Fortune 500 companies and trade associations, he also leads Prime Policy Group client teams in several public policy disciplines.
Dr. Michael S. Farber is team physician for the Brooklyn Nets (NBA), New York Red Bulls (MLS), New Jersey Devils (NHL), and other professional sports teams. He is the Medical Director of Executive Health at Hackensack University Medical Center, Assistant Professor of Medicine at Hackensack Meridian School of Medicine, and a leader in advising companies and professional sports teams in COVID-19 planning for “return to work or play”
Cheryl is a Partner and International Chair, Life Sciences at Mintz Law. Cheryl is an internationally recognized advisor to life sciences companies and some of the industry’s largest investors. She represents biotechnology, medical device, and health technology companies at all stages of their development, from inventors and start-ups to major public corporations, as well as venture capitalists, investment banks, and academic medical centers.
Sunir Chandaria serves as President of Chandaria Family Holdings and manages a portfolio of public and private investments. Sunir was formerly President of LePage’s, a portfolio company that is a leader in office supplies distribution to major retailers around the globe. He is a Member of the Institute of Corporate Directors (ICD) and has served on the Boards of many private and public sector organizations.